APA ציטוט

Klempner, S. J., Raufi, A., & Ou, S. I. (2015). Moving molecularly directed therapies to the first-line in ALK-positive lung cancer: Crizotinib is just the beginning. Transl Lung Cancer Res.

Citação norma Chicago

Klempner, Samuel J., Alexander Raufi, and Sai-Hong Ignatius Ou. "Moving Molecularly Directed Therapies to the First-line in ALK-positive Lung Cancer: Crizotinib Is Just the Beginning." Transl Lung Cancer Res 2015.

ציטוט MLA

Klempner, Samuel J., Alexander Raufi, and Sai-Hong Ignatius Ou. "Moving Molecularly Directed Therapies to the First-line in ALK-positive Lung Cancer: Crizotinib Is Just the Beginning." Transl Lung Cancer Res 2015.